Adiponectin-mediated modulation of hypertrophic signals in the heart
Top Cited Papers
- 21 November 2004
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 10 (12) , 1384-1389
Abstract
Patients with diabetes and other obesity-linked conditions have increased susceptibility to cardiovascular disorders1. The adipocytokine adiponectin is decreased in patients with obesity-linked diseases2. Here, we found that pressure overload in adiponectin-deficient mice resulted in enhanced concentric cardiac hypertrophy and increased mortality that was associated with increased extracellular signal-regulated kinase (ERK) and diminished AMP-activated protein kinase (AMPK) signaling in the myocardium. Adenovirus-mediated supplemention of adiponectin attenuated cardiac hypertrophy in response to pressure overload in adiponectin-deficient, wild-type and diabetic db/db mice. In cultures of cardiac myocytes, adiponectin activated AMPK and inhibited agonist-stimulated hypertrophy and ERK activation. Transduction with a dominant-negative form of AMPK reversed these effects, suggesting that adiponectin inhibits hypertrophic signaling in the myocardium through activation of AMPK signaling. Adiponectin may have utility for the treatment of hypertrophic cardiomyopathy associated with diabetes and other obesity-related diseases.Keywords
This publication has 24 references indexed in Scilit:
- The Metabolic SyndromeCirculation, 2003
- Reactive Oxygen Species Mediate Amplitude-Dependent Hypertrophic and Apoptotic Responses to Mechanical Stretch in Cardiac MyocytesCirculation Research, 2001
- Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart StudyAmerican Heart Journal, 2001
- A Role for AMP-Activated Protein Kinase in Contraction- and Hypoxia-Regulated Glucose Transport in Skeletal MuscleMolecular Cell, 2001
- MEK1/2–ERK1/2 Mediates α1-Adrenergic Receptor-stimulated Hypertrophy in Adult Rat Ventricular MyocytesJournal of Molecular and Cellular Cardiology, 2001
- Cardiac Overexpression of a G q Inhibitor Blocks Induction of Extracellular Signal–Regulated Kinase and c-Jun NH 2 -Terminal Kinase Activity in In Vivo Pressure OverloadCirculation, 2001
- Obesity and insulin resistanceJournal of Clinical Investigation, 2000
- RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overloadJournal of Clinical Investigation, 1999
- A Novel Serum Protein Similar to C1q, Produced Exclusively in AdipocytesJournal of Biological Chemistry, 1995
- High Rates of Fatty Acid Oxidation during Reperfusion of Ischemic Hearts Are Associated with a Decrease in Malonyl-CoA Levels Due to an Increase in 5’-AMP-activated Protein Kinase Inhibition of Acetyl-CoA CarboxylaseJournal of Biological Chemistry, 1995